Immuno-oncology updates from 12th Immunotherapy of Cancer Conference
About this episode
The episode discusses the latest advancements in cancer immunotherapy presented at the 12th Immunotherapy of Cancer Conference.
In this week’s VJOncology podcast, we had the opportunity to attend the 12th Immunotherapy of Cancer (ITOC) Conference, where we explored cutting-edge developments in cancer immunotherapy and tumor biology. Join David Giles of Washington University in St. Louis, MO, Bernard Fox of Providence Cancer Institute, Portland, OR, and Krijn Dijkstra of Netherlands Cancer Institute, Amsterdam, Netherlands as they discuss innovative approaches including live cell and dark antigen vaccines, adoptive cell therapy in melanoma, and tumor-intrinsic mechanisms shaping immune exclusion in colorectal cancer.
More episodes of VJOncology Podcast
- Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs
- Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
- Head and neck cancer awareness month: key trials and evolving treatment strategies
- Lung cancer highlights from the 24th BTOG annual conference
- Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer
- Esophageal cancer awareness month: from multidisciplinary dialogue to clinical impact
Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.